cognitive test battery (CogState Ltd)
90
Structured Review
CogState Ltd
cognitive test battery
Cognitive Test Battery, supplied by CogState Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computerized+cognitive+testing+cogstate/cognitive+test+battery/pmc09014565-22-2-1
Average 90 stars, based on 1 article reviews
Cognitive Test Battery, supplied by CogState Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computerized+cognitive+testing+cogstate/cognitive+test+battery/pmc09014565-22-2-1
Average 90 stars, based on 1 article reviews
cognitive test battery - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Battery:Article Title: COVID-19 associated cognitive impairment: A systematic review Article Snippet: .. , Article Title: Does cannabis affect cognitive functioning in patients with schizophrenia? Article Snippet: .. The Article Title: The effect of opioid-sparing anesthesia regimen on short-term cognitive function after thoracoscopic surgery: a prospective cohort study Article Snippet: .. CogState provided the Article Title: Breaking up prolonged sedentary behavior to improve cardiometabolic health (BREAK2): protocol for a dose-finding adaptive randomization trial. Article Snippet: .. A Article Title: COVID-19 associated cognitive impairment: A systematic review Article Snippet: , Austria , Observational cohort study , To explore the dysfunctions and outcome of COVID-19 survivors after early post-acute rehabilitation , Discharged critical or severe COVID-19 individuals (mean in-hospital stay of 30 days) , 14 patients , 57 (SD ± 10) years∗ , Logical Memory I & II of Wechsler Memory Scale-IV (WMSIV), subtest of the verbal and visual memory test (VVM) and test of attentional performance (TAP) , 29% with cognitive deficits of concentration, memory and/or executive functions. .. , Australia , Prospective cohort study , To determine the prevalence of persistent symptoms, lung function, quality of life, neurocognitive and olfactory abnormalities during the recovery period , 69 days after diagnosis; IQR, 64–83 days. Discharged patients , 78 patients , 47 years (standard deviation, 16 years) , Concentration Assay:Article Title: COVID-19 associated cognitive impairment: A systematic review Article Snippet: .. , other:Article Title: The Influence of Nutritional Status on Brain Development: Benefits of Exclusive Breastfeeding Article Snippet: Lovcevi, (2023) [ ] , To evaluate the dose-response association between breastfeeding duration and cognitive abilities in children aged 5 to 15 years. , Variable according to the research question. , Application of the Peabody Picture Vocabulary Test (to assess language skills), the Matrix Reasoning Subtest of the Wechsler Intelligence Scale (to assess non-verbal intelligence) and the Article Title: Associations of breastfeeding duration and cognitive development from childhood to middle adolescence. Article Snippet: The executive functioning was assessed at 15 years of age via direct cognitive assessment using 3 tests from Article Title: 15 th Conference Clinical Trials Alzheimer’s Disease, November 29–December 2, 2022, San Francisco, CA, USA: Posters (Clinical Trial Alzheimer’s Disease) Article Snippet: Primary objectives were safety of the 2 dose levels, pharmacodynamics of the adrenocorticotropic hormone response, and effects on cognition, using the Biomarker Discovery:Article Title: COVID-19 associated cognitive impairment: A systematic review Article Snippet: , Austria , Observational cohort study , To explore the dysfunctions and outcome of COVID-19 survivors after early post-acute rehabilitation , Discharged critical or severe COVID-19 individuals (mean in-hospital stay of 30 days) , 14 patients , 57 (SD ± 10) years∗ , Logical Memory I & II of Wechsler Memory Scale-IV (WMSIV), subtest of the verbal and visual memory test (VVM) and test of attentional performance (TAP) , 29% with cognitive deficits of concentration, memory and/or executive functions. .. , Australia , Prospective cohort study , To determine the prevalence of persistent symptoms, lung function, quality of life, neurocognitive and olfactory abnormalities during the recovery period , 69 days after diagnosis; IQR, 64–83 days. Discharged patients , 78 patients , 47 years (standard deviation, 16 years) , Standard Deviation:Article Title: COVID-19 associated cognitive impairment: A systematic review Article Snippet: , Austria , Observational cohort study , To explore the dysfunctions and outcome of COVID-19 survivors after early post-acute rehabilitation , Discharged critical or severe COVID-19 individuals (mean in-hospital stay of 30 days) , 14 patients , 57 (SD ± 10) years∗ , Logical Memory I & II of Wechsler Memory Scale-IV (WMSIV), subtest of the verbal and visual memory test (VVM) and test of attentional performance (TAP) , 29% with cognitive deficits of concentration, memory and/or executive functions. .. , Australia , Prospective cohort study , To determine the prevalence of persistent symptoms, lung function, quality of life, neurocognitive and olfactory abnormalities during the recovery period , 69 days after diagnosis; IQR, 64–83 days. Discharged patients , 78 patients , 47 years (standard deviation, 16 years) , |
